This topic has 0 replies, 1 voice, and was last updated 1 month, 2 weeks ago by MS News Today Moderator. Viewing 0 reply threads Author Posts January 18, 2021 at 9:37 am #20546 MS News Today ModeratorParticipant Tecfidera may be an effective option for those with relapsing MS who failed to respond to glatiramer acetate, an observational study suggests. Read more here. What are your thoughts on this news? Author Posts Viewing 0 reply threads You must be logged in to reply to this topic. Log In Username: Password: Keep me signed in Log in with Facebook or Log In